Cellular delivery of antisense oligonucleotides

Author： Lebedeva I.   Benimetskaya L.   Stein C.A.   Vilenchik M.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.50, Iss.1, 2000-07, pp. : 101-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides

By Jaaskelainen I.   Peltola S.   Honkakoski P.   Monkkonen J.   Urtti A.  

European Journal of Pharmaceutical Sciences, Vol. 10, Iss. 3, 2000-05 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

The Antisense Oligonucleotides Decrease Expression of the Cellular Prion

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 1, 2010-01 ,pp. : 23-26

Bentham Science Publishers

Access to resources Recommend Favorite

Oral delivery of siRNA and antisense oligonucleotides

By Akhtar Saghir  

Journal of Drug Targeting, Vol. 17, Iss. 7, 2009-08 ,pp. : 491-495

Informa Healthcare

Access to resources Recommend Favorite

Antisense oligonucleotides: local delivery enhances their therapeutic potential

By Nyce J.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 263-267

Informa Healthcare

Access to resources Recommend Favorite

Microfluidic Assembly of Lipid Nanoparticles for Delivery of Antisense Oligonucleotides

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 9, 2014-09 ,pp. : 823-828

Bentham Science Publishers

Access to resources Recommend Favorite